DentalXChange Announces the Relaunch of Dental Billing Services, Bringing Growth and Supplemental Support for DentalXChange Clients
IRVINE, Calif., January 9, 2024 (Newswire.com)
–
DentalXChange, the dental payments platform, announces the relaunch of Dental Billing Services. These se…
Mazree and Capstone Health Alliance Join Forces to Revolutionize Equipment Value Recovery in Healthcare
Mazree, a cutting-edge provider of medical equipment disposition services, has announced a strategic partnership with Capstone Health Alliance, one of the largest regional group purchasing organizations in the U.S. hea…
Glidewell Publishes Inaugural Edition of Integrate™ Magazine
A new publication dedicated to making implant dentistry more accessible to all.
NEWPORT BEACH, Calif., January 5, 2…
Metrodora Institute Announces New Chief Scientific Officer
Rohit Gupta, a Nationally Recognized Scientist, Biobank and Data Expert, is Named as Metrodora Institute’s New Chief Scientific Officer and Head of R&D
SALT LAKE CITY, January 5, 2024 (Newswire.com)
–
Metrodora Institute, a leading multispecialty healthcare institute, announces the hiring of Rohit Gupta, a nationally recognized scientist, biobank, and data expert, as its new Chief Scientific Officer and Head of R&D. This move comes on the heels of other recent leadership announcements, including Dr. Brent Goodman as Metrodora’s Chief Medical Officer. Gupta’s hire solidifies the continuing commitment to Metrodora’s vision of reimagining care across multisystem disorders. By breaking down the silos between clinical care and scientific research, Dr. Goodman and Gupta, as leading pioneers in their respective fields, will collaborate to make this model come to life, ensuring that patient care and access inform and fuel research to direct a more personalized approach.
Gupta will enable Metrodora Institute to drive cutting-edge clinical trials, develop new diagnostic tests, lead collaborations in both academia and industry circles, launch landmark studies and bring new insights and treatments. “Throughout my career, I’ve been fortunate to be a part of and witness the impact of precision medicine in areas like cancer, autoimmune, neurology, and infectious diseases. I’m humbled to be joining Metrodora, as this mission is personal for me. My wife and millions like her have suffered long enough with these chronic, debilitating, and misunderstood conditions, such as CFS/ME, POTS, Long COVID, Ehlers Danlos Syndrome (EDS), ALS, Sjogren’s, and many more,” says Gupta. One of his top priorities this winter is launching a much-needed study to characterize multisystem dysfunction associated with Metrodora Institute’s patients. “Often times, patients present with multiple overlapping conditions, and, to date, there is no standardized way to diagnose and treat these patients at the root of the issue. By converging patient care with real-world data and best-in-class genetic and immune technologies, we will start to uncover new biological drivers and advance effective interventions to improve the quality of life for our patients.”
Gupta brings over two decades of life science experience to his new role as Chief Scientific Officer and Head of R&D at Metrodora Institute. He has extensive experience in leading research enterprises and developing innovative medical technology in both academia and industry sectors. He has spearheaded innovation, R&D, and business development efforts for several companies, with a passion to improve access to healthcare for millions through novel laboratory diagnostics and data-driven solutions. Known as one of the world’s foremost biobanking experts, Gupta has also pioneered new methodologies to rethink how scientific discovery using biospecimens and data is used as a vehicle to drive clinical applications.
“We couldn’t be more thrilled to welcome Rohit Gupta to Metrodora,” said John Wirthlin, CEO, Metrodora Institute. “He brings with him unique expertise across science and business that will accelerate our vision. With his leadership, we can be certain that Metrodora Institute will achieve its goals of developing and adopting new solutions that will improve the lives of the patients we serve.”
An active leader within the scientific community, Gupta has twice served as the Chairman of the International Society for Biological and Environmental Repositories (ISBER) annual conference, is the Section Editor for “Emerging Markets and Technology” of the peer-reviewed journal “Biobanking and Biopreservation,” and won multiple awards for leadership. Among his many professional accomplishments, Gupta also dedicates time to serve in the non-profit space, including advisory board roles that bring medical advancements to underserved populations.
About Metrodora Institute — Located in Salt Lake City, Utah, the Metrodora Institute was founded in 2021 with the vision of reimagining care for patients with complex multisystem disorders. Metrodora is uniquely positioned to advance the latest clinical care and develop and commercialize new diagnostic tests and therapeutics for patients living with these often-debilitating conditions. Metrodora Institute has created an innovative offering with a collaborative multidisciplinary approach to medicine. Metrodora currently treats neurological, gastrointestinal, immunological, autoimmune, pain and metabolic disorders.
Contact Information:
Kainoa Clark
Chief Marketing Officer
801-473-2119
Original Source:
Metrodora Institute Announces New Chief Scientific Officer
Zen Dog Veterinary Care Expands Services to Westchester
Zen Dog Veterinary Care – At Home Pet Euthanasia Zen Dog Veterinary Care – At Home Pet Euthanasia
NEW YORK, January 5, 2024 (Newswire.com)
–
Zen Dog V…
Radiance Therapeutics to Present at the Biotech Showcase 2024 in San Francisco
EMERYVILLE, Calif., January 5, 2024 (Newswire.com)
–
Radiance Therapeutics, an innovation leader in ophthalmic devices, is delighted to announce that its CEO,…
Recovery Delivered Expands Services to Accept Medicaid in Ohio for Online Suboxone to Treat Opioid Addiction
Seeing a Suboxone doctor in Ohio just became much more affordable. Patients can now use their Ohio Medicaid to cover the cost of telemedicine visits with licensed Suboxone doctors.
…
AMC Health Advances the Remote Management of Diabetes Through CGM Data Integration
Virtual Care Solution Integrates Critical Data from Popular Continuous Glucose Monitoring Systems
NEW YORK, January 4, 20…
LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready Robotic System for FDA Submission
LEM Surgical Logo Company Logo of LEM Surgical
BERN, Switzerland, January 4, 2024 (Newswire.com)
–
LEM Surgical AG, an innovative surgical robotics co…
Clearview Treatment Programs Certified by PsychArmor as a ‘Veteran Ready’ Organization
BRENTWOOD, Tenn., January 4, 2024 (Newswire.com)
–
Odyssey Behavioral Healthcare, a leading provider of mental health, addiction, and eating disorder treatment services, proudly announces that Clearview Treatment Programs in Southern California has been certified by PsychArmor as a “Veteran Ready Healthcare Organization.” The facility provides needed mental health, PTSD, and addiction services for military Veterans and their families as a participating partner in the VA Community Care Network.
According to recent reports from the U.S. Department of Veteran Affairs and the National Institute of Drug Abuse:
- The Veteran suicide rate has risen over the past 20 years, with 2020 seeing a rate that was 66.2% higher than non-Veteran adults.
- 37-50% of Veterans returning from Afghanistan and Iraq have been diagnosed with a mental health disorder associated with a substance use disorder (SUD), and 63% of those diagnosed with SUDs also met the criteria for post-traumatic stress disorder (PTSD).
- Fewer than 50% of returning Veterans in need receive any mental health treatment.
“Odyssey is committed to addressing the specific challenges faced by military service members by strengthening our understanding of military culture,” said Richard Clark, CEO of Odyssey. “Expanding our partnership with PsychArmor to deepen our understanding plays an important part in how Odyssey provides superior clinical care for those who have served our nation.”
In collaboration with PsychArmor, a nonprofit organization dedicated to equipping civilian professionals, the team at Clearview Treatment Programs completed comprehensive training to receive the prestigious “Veteran Ready” certification. This facility joins Lifeskills South Florida, Silver Pines, Pasadena Villa Outpatient – McLean, and Pasadena Villa Outpatient – Norfolk as a “Veteran Ready” Healthcare Organization within Odyssey’s network.
Clearview understands the importance of providing culturally competent care to the military community. The partnership with PsychArmor empowers its treatment team to deliver compassionate and effective care that better supports the unique needs of veterans and their families.
Learn more about Clearview Treatment Programs by visiting its website.
About Odyssey Behavioral Healthcare
Odyssey, formed in 2015, has a diverse clinical network of services treating adults and adolescents for eating disorders, psychiatric disorders, dual diagnosis, and other addictive disorders. Odyssey provides a continuum of care within our Psychiatric Network and Eating Disorder Network, including inpatient, intensive residential, partial hospitalization, outpatient services, detoxification, and transitional living at over 20 locations and affiliated Odyssey Outpatient Network clinics in nine states with over 600 beds.
About PsychArmor
PsychArmor is a California nonprofit public benefit corporation providing education and support to individuals and organizations that work with, live with, and care for American service members, Veterans, and their families.
Contact Information:
Vicki Smith
Chief Marketing Officer, Odyssey Behavioral Healthcare
615-864-8145
Original Source:
Clearview Treatment Programs Certified by PsychArmor as a ‘Veteran Ready’ Organization